# US 2011/0087037 A1 · Synthesis of ring b abeo-sterols as novel inhibitors of mycobacterium tuberculosis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0087037 A1
- Document ID: US20110087037A1
- Status: Published application
- Kind: A1
- Application number: 12/740,901
- Filed: 2008-10-31
- Published: 2011-04-14
- Earliest claimed: 2007-10-31
- Assignees: Office of Intellectual Property and Technology Vic
- Inventors: Abimael D. Rodriguez-Pierluissi; Xiaomei Wei
- Web page: https://patentgrep.com/patent/US20110087037A1

## CPC

- C07J 61/00: Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms
- C07J 9/00: Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J: STEROIDS (seco-steroids C07C)

## Abstract

Novel 3β-hydroxy-Δ5-steroid analogs possessing a contracted cyclopentane B-ring provide good inhibitory activity against Mycobacterium tuberculosis. The 5(6→7)abeo-sterol nucleus present in compounds of the invention represents a novel scaffold for the development of new antitubercular agents.

## Claims

### Claim 1

A method of synthesizing abeo-sterol analogs comprising:
mixing a sterol compound with a first solvent;
reacting said mixture with ozone at a first predetermined temperature for a first predetermined amount of time;
removing said first solvent from said mixture;
stirring the resulting mixture with a mixture of an organosulfur compound and a second solvent at a second predetermined temperature for a second predetermined amount of time;
stirring the resulting mixture with a suitable base and a third solvent at a third predetermined temperature for a third predetermined amount of time;
removing the remaining solvents; and
purifying the final resulting mixture.

### Claim 2 (depends on 1)

The method of claim 1, wherein said first predetermined temperature is about −78 Celsius degrees.

### Claim 3 (depends on 1)

The method of claim 1, wherein said first predetermined amount of time is about 15 minutes.

### Claim 4 (depends on 1)

The method of claim 1, wherein said first solvent comprises methylene chloride.

### Claim 5 (depends on 1)

The method of claim 1, wherein said organosulfur compound comprises dimethyl sulfide.

### Claim 6 (depends on 1)

The method of claim 1, wherein said second solvent comprises an ethereal solution.

### Claim 7 (depends on 1)

The method of claim 1, wherein said second predetermined temperature is about 25 Celsius degrees.

### Claim 8 (depends on 1)

The method of claim 1, wherein said second predetermined amount of time is not less than about 12 hours.

### Claim 9 (depends on 1)

The method of claim 1, wherein said third predetermined temperature is about 25 Celsius degrees.

### Claim 10 (depends on 1)

The method of claim 1, wherein said third predetermined amount of time is about 2 hours.

### Claim 11 (depends on 1)

The method of claim 1, wherein said third solvent comprises a methanolic solution.

### Claim 12 (depends on 1)

The method of claim 1, wherein said suitable base comprises KOH.

### Claim 13 (depends on 1)

The method of claim 1, wherein removing the remaining solvents is done in vacuo.

### Claim 14 (depends on 1)

The method of claim 1, wherein the final resulting mixture is purified by column chromatography.

### Claim 15 (depends on 1)

The method of claim 1, wherein said abeo-sterols show inhibition against Mycobacterium tuberculosis.

### Claim 16

An abeo-sterol analog especially suitable for inhibition against Mycobacterium tuberculosis having the formula:
where R is an alkyl side chain.

### Claim 17 (depends on 16)

The abeo-sterol of claim 16, wherein

### Claim 18 (depends on 16)

The abeo-sterol of claim 16, wherein

### Claim 19 (depends on 16)

The abeo-sterol of claim 16, wherein

### Claim 20 (depends on 16)

The abeo-sterol of claim 16, wherein

### Claim 21 (depends on 16)

The abeo-sterol of claim 16, wherein

### Claim 22 (depends on 16)

The abeo-sterol of claim 16, wherein said abeo-sterol is synthesized from a sterol having the formula:
where R1 is an alkyl side chain.

### Claim 23 (depends on 22)

The abeo-sterol of claim 22, wherein

### Claim 24 (depends on 22)

The abeo-sterol of claim 22, wherein

### Claim 25 (depends on 22)

The abeo-sterol of claim 22, wherein

### Claim 26 (depends on 22)

The abeo-sterol of claim 22, wherein
